Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bronchoscopy-related outbreaks and pseudo-outbreaks: A systematic review.
Kakoullis L, Economidou S, Mehrotra P, Panos G, Karampitsakos T, Stratakos G, Tzouvelekis A, Sampsonas F. Kakoullis L, et al. Among authors: sampsonas f. Infect Control Hosp Epidemiol. 2024 Apr;45(4):509-519. doi: 10.1017/ice.2023.250. Epub 2023 Dec 15. Infect Control Hosp Epidemiol. 2024. PMID: 38099453 Review.
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T, Galaris A, Chrysikos S, Papaioannou O, Vamvakaris I, Barbayianni I, Kanellopoulou P, Grammenoudi S, Anagnostopoulos N, Stratakos G, Katsaras M, Sampsonas F, Dimakou K, Manali ED, Papiris S, Tourki B, Juan-Guardela BM, Bakakos P, Bouros D, Herazo-Maya JD, Aidinis V, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Respir Res. 2023 Nov 14;24(1):279. doi: 10.1186/s12931-023-02551-x. Respir Res. 2023. PMID: 37964265 Free PMC article.
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I, Lambiri I, Papaioannou O, Zarkadi E, Antonakis E, Pandi A, Malakounidou E, Sampsonas F, Makrodimitri S, Chrysikos S, Hillas G, Dimakou K, Tzanakis N, Sipsas NV, Antoniou K, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Front Med (Lausanne). 2023 Apr 13;10:1194925. doi: 10.3389/fmed.2023.1194925. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37122328 Free PMC article.
SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts.
Karampitsakos T, Galaris A, Barbayianni I, DeIuliis G, Ahangari F, Sampsonas F, Sotiropoulou V, Aidinis V, Bennett AM, Herazo-Maya JD, Xylourgidis N, Bakakos P, Bouros D, Kaminski N, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Diagnostics (Basel). 2023 Mar 18;13(6):1166. doi: 10.3390/diagnostics13061166. Diagnostics (Basel). 2023. PMID: 36980473 Free PMC article.
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I, Lambiri I, Papaioannou O, Zarkadi E, Antonakis E, Pandi A, Malakounidou E, Sampsonas F, Makrodimitri S, Chrysikos S, Hillas G, Dimakou K, Tzanakis N, Sipsas NV, Antoniou K, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Front Med (Lausanne). 2023 Jan 17;9:1083264. doi: 10.3389/fmed.2022.1083264. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36733935 Free PMC article.
Clinical features and outcomes of patients with myositis associated-interstitial lung disease.
Karampitsakos T, Tzilas V, Papaioannou O, Chrysikos S, Vasarmidi E, Juge PA, Vizirianaki S, Bibaki E, Reppa A, Sidiropoulos P, Katsaras M, Sotiropoulou V, Tsiri P, Koulousousa E, Theochari E, Tsirikos G, Christopoulos I, Malakounidou E, Zarkadi E, Sampsonas F, Hillas G, Karageorgas T, Daoussis D, Kalogeropoulou C, Dimakou K, Tzanakis N, Borie R, Dieudé P, Antoniou K, Crestani B, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Front Med (Lausanne). 2023 Jan 9;9:1096203. doi: 10.3389/fmed.2022.1096203. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698813 Free PMC article.
Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis.
Papaioannou O, Karampitsakos T, Tsiri P, Sotiropoulou V, Koulousousa E, Tasiopoulos P, Schinas G, Katsaras M, Zarkadi E, Malakounidou E, Georgiopoulou V, Sampsonas F, Spyridonidis A, Akinosoglou K, Marangos M, Tzouvelekis A. Papaioannou O, et al. Among authors: sampsonas f. Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7705-7712. doi: 10.26355/eurrev_202210_30047. Eur Rev Med Pharmacol Sci. 2022. PMID: 36314348 Free article.
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.
Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos AP, Malakounidou E, Zarkadi E, Tsirikos G, Georgiopoulou V, Sotiropoulou V, Koulousousa E, Chourpiliadi C, Matsioulas A, Lagadinou M, Sampsonas F, Akinosoglou K, Marangos M, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Clin Microbiol Infect. 2023 Mar;29(3):372-378. doi: 10.1016/j.cmi.2022.10.015. Epub 2022 Oct 20. Clin Microbiol Infect. 2023. PMID: 36273769 Free PMC article.
70 results